Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Oct;80(4):1064–1067. doi: 10.1172/JCI113161

Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

M H Mogard 1, V Maxwell 1, B Sytnik 1, J H Walsh 1
PMCID: PMC442347  PMID: 3654970

Abstract

The present study was designed to evaluate neurotensin as a hormonal regulator of gastric acid secretion in man. After a fat-rich meal, the strongest known stimulus of neurotensin release, plasma neurotensin-like immunoreactivity (NTLI) was elevated from 7.6 +/- 1.9 to 15.5 +/- 2.5 pM. Plasma NTLI was measured with antiserum L170, which requires the biologically active carboxyl-terminal hexapeptide of the neurotensin molecule for recognition and does not crossreact significantly with any known natural catabolite in human plasma. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 resulted in a plasma level of 14.7 +/- 2.1 pM, similar to the maximal physiological level observed after the fat-rich meal. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 during 2 h, however, failed to significantly inhibit peptone meal-stimulated gastric acid secretion measured by intragastric titration. The 2-h acid output to peptone was 40.8 +/- 6.2 and 41.3 +/- 6.9 mmol during the vehicle and the neurotensin infusion, respectively. Intravenous infusion of neurotensin at 100 or 400 pmol X kg-1 h-1 did not affect acid output, whereas at 1,600 pmol X kg-1 h-1, which resulted in a plasma neurotensin concentration of 725 +/- 80 pM, significantly reduced peptone meal-stimulated gastric acid secretion. The neurotensin-induced inhibition of acid output was independent of the hormone gastrin. The present results provide evidence against a hormonal role for neurotensin in the regulation of meal-stimulated gastric acid secretion in man.

Full text

PDF
1064

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson S., Chang D., Folkers K., Rosell S. Inhibition of gastric acid secretion in dogs by neurotensin. Life Sci. 1976 Aug 1;19(3):367–370. doi: 10.1016/0024-3205(76)90040-0. [DOI] [PubMed] [Google Scholar]
  2. Blackburn A. M., Fletcher D. R., Bloom S. R., Christofides N. D., Long R. G., Fitzpatrick M. L., Baron J. H. Effect of neurotensin on gastric function in man. Lancet. 1980 May 10;1(8176):987–989. doi: 10.1016/s0140-6736(80)91434-8. [DOI] [PubMed] [Google Scholar]
  3. Carraway R., Hammer R. A., Leeman S. E. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material. Endocrinology. 1980 Aug;107(2):400–406. doi: 10.1210/endo-107-2-400. [DOI] [PubMed] [Google Scholar]
  4. Carraway R., Leeman S. E. Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J Biol Chem. 1976 Nov 25;251(22):7045–7052. [PubMed] [Google Scholar]
  5. Carraway R., Leeman S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854–6861. [PubMed] [Google Scholar]
  6. Carraway R., Ruane S. E., Kim H. R. Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: apparent conservation of the COOH-terminal region during evolution. Peptides. 1982 Mar-Apr;3(2):115–123. doi: 10.1016/0196-9781(82)90038-9. [DOI] [PubMed] [Google Scholar]
  7. Hammer R. A., Carraway R. E., Leeman S. E. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components. J Clin Invest. 1982 Jul;70(1):74–81. doi: 10.1172/JCI110605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hammer R. A., Leeman S. E., Carraway R., Williams R. H. Isolation of human intestinal neurotensin. J Biol Chem. 1980 Mar 25;255(6):2476–2480. [PubMed] [Google Scholar]
  9. Helmstaedter V., Taugner C., Feurle G. E., Forssmann W. G. Localization of neurotensin-immunoreactive cells in the small intestine of man and various mammals. Histochemistry. 1977 Jul 18;53(1):35–41. doi: 10.1007/BF00511208. [DOI] [PubMed] [Google Scholar]
  10. Holst Pedersen J., Skov Olsen P., Kirkegaard P. Effect of neurotensin and neurotensin fragments on gastric acid secretion in man. Regul Pept. 1986 Aug;15(1):77–86. doi: 10.1016/0167-0115(86)90078-9. [DOI] [PubMed] [Google Scholar]
  11. Kitabgi P., Kwan C. Y., Fox J. E., Vincent J. P. Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides. 1984 Sep-Oct;5(5):917–923. doi: 10.1016/0196-9781(84)90117-7. [DOI] [PubMed] [Google Scholar]
  12. Kleibeuker J. H., Eysselein V. E., Maxwell V. E., Walsh J. H. Role of endogenous secretin in acid-induced inhibition of human gastric function. J Clin Invest. 1984 Feb;73(2):526–532. doi: 10.1172/JCI111239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee Y. C., Allen J. M., Uttenthal L. O., Roberts P. M., Gill S. S., Bloom S. R. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Dig Dis Sci. 1985 Feb;30(2):129–133. doi: 10.1007/BF01308198. [DOI] [PubMed] [Google Scholar]
  14. Lee Y. C., Allen J. M., Uttenthal L. O., Walker M. C., Shemilt J., Gill S. S., Bloom S. R. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma. J Clin Endocrinol Metab. 1984 Jul;59(1):45–50. doi: 10.1210/jcem-59-1-45. [DOI] [PubMed] [Google Scholar]
  15. Mogard M., Böttcher W., Kauffman G. L., Jr, Washington J., Walsh J. H. Neurotensin-like immunoreactivity released into the portal vein by duodenal acidification in the dog. Scand J Gastroenterol. 1986 Jan;21(1):97–103. doi: 10.3109/00365528609034630. [DOI] [PubMed] [Google Scholar]
  16. Olsen P. S., Pedersen J. H., Kirkegaard P., Been H., Stadil F., Fahrenkrug J., Christiansen J. Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy. Gut. 1984 May;25(5):481–484. doi: 10.1136/gut.25.5.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Quirion R., Rioux F., Regoli D., St-Pierre S. Pharmacological studies of neurotensin, several fragments and analogous in the isolated perfused rat heart. Eur J Pharmacol. 1980 Sep 5;66(4):257–266. doi: 10.1016/0014-2999(80)90457-4. [DOI] [PubMed] [Google Scholar]
  18. Reinecke M., Carraway R. E., Falkmer S., Feurle G. E., Forssmann W. G. Occurrence of neurotensin-immunoreactive cells in the digestive tract of lower vertebrates and deuterostomian invertebrates. A correlated immunohistochemical and radioimmunochemical study. Cell Tissue Res. 1980;212(2):173–183. doi: 10.1007/BF00233953. [DOI] [PubMed] [Google Scholar]
  19. Rökaeus A. Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin. Acta Physiol Scand Suppl. 1981;501:1–62. [PubMed] [Google Scholar]
  20. Shulkes A., Chick P., Wong H., Walsh J. H. A radioimmunoassay for neurotensin in human plasma. Clin Chim Acta. 1982 Oct 13;125(1):49–58. doi: 10.1016/0009-8981(82)90044-4. [DOI] [PubMed] [Google Scholar]
  21. Skov Olsen P., Holst Pedersen J., Kirkegaard P., Stadil F., Fahrenkrug J., Christiansen J. Neurotensin inhibits meal-stimulated gastric acid secretion in man. Scand J Gastroenterol. 1983 Nov;18(8):1073–1076. doi: 10.3109/00365528309181843. [DOI] [PubMed] [Google Scholar]
  22. Theodorsson-Norheim E., Rosell S. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Regul Pept. 1983 Jul;6(3):207–218. doi: 10.1016/0167-0115(83)90139-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES